Medically reviewed by Lindsay Cook, PharmD Weight loss medications can be an effective option for people struggling to lose ...

Tirzepatide is the active ingredient in Zepbound, approved by the Food and Drug Administration (FDA) specifically for weight loss. Semaglutide was initially approved under the brand name Ozempic ...

Compounded versions could make up as much as 40% of the semaglutide market, said Novo Nordisk CEO Lars Fruergaard Jorgensen ...

A Medicine study used artificial intelligence to discover a naturally occurring molecule, specifically, a peptide, that ...

Ozempic (semaglutide) is a prescription drug that some doctors may prescribe off-label for weight loss. The drug isn’t approved for this use, but it may be helpful for weight loss and weight ...

"As expected, semaglutide patients lost weight — about 4 kg — and while there was a weak relationship between change in weight and maximum walking distance in both groups, this was not ...

Semaglutide, a glucagon-like peptide 1 (GLP-1) agonist, significantly improved maximal walking distance in people with ...

Some people have used Ozempic for its off-label use to manage weight, but the medication is approved to treat type 2 diabetes. Semaglutide also delays gastric emptying, or the process of food ...

The way people are accessing GLP-1 medications Semaglutide and Tirzepatide is going to become very limited after the drugs were taken off the FDA’s shortage list.

People taking an oral formulation of the glucagon-like peptide-1 (GLP-1) agonist semaglutide were 14% less likely than those taking a placebo to experience cardiovascular death, heart attack or stroke ...

Wegovy is just one of the popular weight loss injections experiencing shortages. Due to increased demand, some doses of Wegovy (semaglutide) are currently in short supply. Depending on the ...

Stephanie Anderson Witmer is a freelance journalist based in Pennsylvania. Her work has been published in other top magazines and digital publications, including Prevention, Good Housekeeping ...